WhatsApp

Is Major Cancer Surgery Safe for Older Patients?

You are here >> Home > Latest Updates > HIPEC > Is Major…

Survival and morbidity in elderly patients treated with cytoreductive surgery and HIPEC for colorectal peritoneal metastases a population-based .DOI 10.108002656736.2026.26

Colorectal cancer can sometimes spread to the lining of the abdomen. This is called peritoneal metastases. One treatment option is a complex operation called cytoreductive surgery combined with heated chemotherapy, also known as HIPEC. The goal is to remove visible cancer and then destroy remaining cells with heated medicine placed inside the abdomen.

This treatment has helped many patients live longer. Still, doctors and families often worry about age. Is this surgery too risky for people aged 75 or older?

This large study from Sweden looked at real-world outcomes to answer that question. Nearly 600 patients were included. All had colorectal cancer that spread inside the abdomen and were treated with surgery and HIPEC. The researchers compared patients aged 74 and younger with those aged 75 and older.

The results were reassuring. Older patients lived just as long as younger patients after treatment. Cancer-free time was also similar between the two groups. Age alone did not shorten survival.

Safety was another key concern. Serious complications happened at similar rates in both age groups. Older patients did not have higher death rates during hospital stay. None of the patients aged 75 or older died in the hospital after surgery. The need for repeat surgery was also similar.

What mattered most for outcomes was not age. Survival was more strongly affected by how much cancer was present and how completely it could be removed. Patients with less widespread disease and successful tumor removal did better, regardless of age.

For patients and families, this study brings an important message. Being older does not automatically mean this treatment is unsafe or ineffective. Careful patient selection is key. Overall health, cancer spread, and recovery potential matter more than the number of birthdays.

These findings support shared decision-making. Older adults should be evaluated fairly and individually. With the right selection, this intensive treatment can offer meaningful benefit without added risk.

Rate this post
dr swati shah - uro & gynec cancer surgeon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.